Literature DB >> 13403127

The relapse state in typhoid fever treated with chloramphenicol.

K C WATSON.   

Abstract

Entities:  

Keywords:  CHLORAMPHENICOL/therapeutic use; TYPHOID FEVER/therapy

Mesh:

Substances:

Year:  1957        PMID: 13403127     DOI: 10.4269/ajtmh.1957.6.72

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


× No keyword cloud information.
  8 in total

1.  CLINICAL TRIALS WITH AMPICILLIN IN TYPHOID FEVER AND PARATYPHOID A.

Authors:  L MANRIQUEZ; M SALCEDO; J M BORGONO; E MARZULLO; R KRALJEVIC; L PAREDES; R VALDIVIESO
Journal:  Br Med J       Date:  1965-07-17

2.  Typhoid fever: treatment failure and multiple relapses with trimethoprim-sulfamethoxazole and chloramphenicol therapy.

Authors:  D Portnoy; S Seah
Journal:  Can Med Assoc J       Date:  1979-05-19       Impact factor: 8.262

3.  Enteric fever--a comparative study of adult and paediatric cases.

Authors:  S K Sen; A C Mahakur
Journal:  Indian J Pediatr       Date:  1972-11       Impact factor: 1.967

4.  Relationship of chloramphenicol therapy with typhoid relapse.

Authors:  S Ghosh; P C Khanduja; K N Agarwal
Journal:  Indian J Pediatr       Date:  1968-06       Impact factor: 1.967

5.  Pathogenesis of typhoid fever.

Authors:  K D Moudgil; B S Narang
Journal:  Indian J Pediatr       Date:  1985 Jul-Aug       Impact factor: 1.967

6.  Development of immune response during typhoid fever in man.

Authors:  V N Sarma; A N Malaviya; R Kumar; O P Ghai; M M Bakhtary
Journal:  Clin Exp Immunol       Date:  1977-04       Impact factor: 4.330

7.  Studies of cellular and humoral immunity in typhoid fever and TAB vaccinated subjects.

Authors:  S K Dham; R A Thompson
Journal:  Clin Exp Immunol       Date:  1982-05       Impact factor: 4.330

8.  Immunological study of typhoid: immunoglobulins, C3, antibodies, and leukocyte migration inhibition in patients with typhoid fever and TAB-vaccinated individuals.

Authors:  R Kumar; A N Malaviya; R G Murthy; M Venkataraman; L N Mohapatra
Journal:  Infect Immun       Date:  1974-12       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.